(NP (NP (NN Characterization)) (PP (IN of) (NP (NP (JJ Grb2-binding) (NNS proteins)) (PP (IN in) (NP (NP (JJ human) (NNS platelets)) (VP (VBN activated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN Fc) (NN gamma) (NN RIIA) (NN cross-linking)))))))) (. .))
(S (NP-SBJ-68 (ADJP (NN Glutathione-S-transferase) (-LRB- -LRB-) (NN GST) (-RRB- -RRB-) (NN -Grb2)) (NN fusion) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN used) (NP (-NONE- *-68)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (JJ Grb2-binding) (NNS proteins))) (PP (IN in) (NP (NP (NN platelet) (NN activation)) (PP (IN by) (NP (NP (DT the) (NN platelet) (NN low-affinity) (NN IgG) (NN receptor)) (, ,) (NP (NN Fc) (NN gamma) (NN RIIA))))))))))))) (. .))
(S (NP-SBJ (NP (CD Two) (NN tyrosine) (NNS phosphoproteins)) (PP (IN of) (NP (QP (CD 38) (CC and) (CD 63)) (NN kD)))) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN Grb2))))) (PP-TMP (VBG following) (NP (NP (NN Fc) (NN gamma) (NN RIIA) (NN stimulation)) (PP (IN of) (NP (NNS platelets)))))) (. .))
(S (NP-SBJ-69 (DT Both)) (VP-COOD (VP (VBP are) (ADJP-PRD (JJ located) (PP (IN in) (NP (DT the) (JJ particulate) (NN fraction)))) (PP-TMP (VBG following) (NP (NN platelet) (NN activation)))) (CC and) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-69)) (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (DT a) (NN GST-construct)) (VP (VBG containing) (NP (NP (DT the) (NP-COOD (NP (NN SH2)) (CC and) (NP (NN SH3))) (NNS domains)) (PP (IN of) (NP (NN phospholipase) (NN C) (NN gamma) (CD 1))))))))))))) (. .))
(S (NP-SBJ (NN p38)) (VP-COOD (VP (ADVP (RB also)) (VBZ forms) (NP (DT a) (NN complex)) (PP (IN with) (NP (DT the) (NN tyrosine) (NN kinase) (NN csk))) (PP (IN in) (NP (VBN stimulated) (NNS cells)))) (CC and) (VP (VBZ is) (NP-PRD (NP (DT a) (NN substrate)) (PP (IN for) (NP (DT the) (NN kinase)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN SH3) (NNS domains)) (PP (IN of) (NP (NN Grb2)))) (VP (VBP form) (NP (DT a) (JJ stable) (NN complex)) (PP (IN with) (NP-COOD (NP (NN SOS1)) (CC and) (NP (NP (CD two) (NNS proteins)) (PP (IN of) (NP-COOD (NP (CD 75) (NN kD)) (CC and) (NP (CD 120) (NN kD)))) (, ,) (SBAR (WHNP-71 (WDT which)) (S (NP-SBJ (-NONE- *T*-71)) (VP (VBP undergo) (NP (NN tyrosine) (NN phosphorylation)) (PP (IN in) (NP (ADJP (NP (NN Fc) (NN gamma) (NN RIIA)) (JJ stimulated)) (NNS cells)))))))))) (. .))
(S (NP-SBJ-74 (DT The) (JJ 75-kD) (NN protein)) (VP (VBZ is) (VP-COOD (VP (VBN recognized) (NP (-NONE- *-74)) (PP (IN by) (NP-LGS (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN SLP-76)) (, ,) (SBAR (WHNP-75 (WDT which)) (S (NP-SBJ-76 (-NONE- *T*-75)) (VP (VBZ has) (ADVP-TMP (RB recently)) (VP (VBN been) (VP (VBN isolated) (NP (-NONE- *-76)) (PP (IN from) (NP (NN T) (NNS cells))))))))))))) (CC and) (VP (VBN sequenced) (NP (-NONE- *-74))))) (. .))
(S (NP-SBJ-77 (NP (NN Tyrosine) (NN phosphorylation)) (PP (IN of) (NP-COOD (NP (NN p38)) (CC and) (NP (NN p63))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN observed) (NP (-NONE- *-77)) (PP (IN in) (NP (NP (NNS platelets)) (VP (VBN stimulated) (NP (-NONE- *)) (PP-COOD (PP (IN by) (NP-LGS (DT the) (ADJP (NN tyrosine) (JJ kinase-linked)) (NN receptor) (NN agonist) (NN collagen))) (CC and) (PP (IN by) (NP-LGS (DT the) (ADJP (NN G) (JJ protein-coupled)) (NN receptor) (NN agonist) (NN thrombin))))))) (, ,) (SBAR (IN although) (S (NP-SBJ-78 (NP (NN phosphorylation)) (PP (IN of) (NP (NN SLP-76)))) (VP (VBZ is) (ADVP (RB only)) (VP (VBN observed) (NP (-NONE- *-78)) (PP (IN in) (NP (JJ collagen-stimulated) (NNS platelets))))))))) (. .))
(S (NP-SBJ-COOD-79 (NP (NN p38)) (CC and) (NP (NN p63))) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (NN docking) (NN site)) (PP (IN for) (NP (NN Grb2)))) (, ,) (S (NP-SBJ (-NONE- *-79)) (ADVP (RB thereby)) (VP (VBG linking) (NP (NN Grb2) (JJ SH3-binding) (NNS proteins) (NP-COOD (NP (NN SOS1)) (, ,) (NP (NN SLP-76)) (, ,) (CC and) (NP (NN p120)))) (PP (TO to) (NP (JJ downstream) (NN signalling) (NNS events))))))) (. .))
